DANIEL COX: Open Payments
NPI 1376056234 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 95 payments from 21 companies in 2025. Trend: 2023 $2,916 · 2024 $2,515 · 2025 $2,128
Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 24 | $459 |
| Janssen Biotech, Inc. | 5 | $210 |
| ABBVIE INC. | 12 | $206 |
| Antares Pharma, Inc. | 8 | $165 |
| Boston Scientific Corporation | 2 | $159 |
| Olympus America Inc. | 8 | $150 |
| Verity Pharmaceuticals Inc. | 5 | $121 |
| Endo USA, Inc. | 5 | $112 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $97 |
| Teleflex LLC | 3 | $68 |
Products named: GEMTESA, XYOSTED, iTIND System, BOTOX, Axonics, RYBREVANT, PYLARIFY, ERLEADA.
Industry payments across WA — which companies pay providers there.
